Taro Pharm Inds (TARO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 223,646 | 129,976 | 67,428 | 210,079 | 123,651 |
| Depreciation Amortization | 13,738 | 8,815 | 4,299 | 16,496 | 12,022 |
| Income taxes - deferred | 741 | -1,705 | 1,575 | 56,007 | 61,540 |
| Accounts receivable | 67,986 | 44,427 | 49,582 | -277 | -22,253 |
| Accounts payable and accrued liabilities | N/A | -6,306 | -17,408 | 9,049 | 3,513 |
| Other Working Capital | 70,001 | 29,646 | 34,827 | 7,433 | -24,001 |
| Other Operating Activity | -110,983 | -47,203 | -57,863 | 24,902 | 71,323 |
| Operating Cash Flow | $265,129 | $157,650 | $82,440 | $323,689 | $225,795 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 250,245 | 137,153 | -56,299 | -609,458 | -372,683 |
| PPE Investments | -19,526 | -12,161 | -6,078 | -25,811 | -17,742 |
| Purchase Of Investment | 70,685 | N/A | 70,685 | 396,281 | 187,725 |
| Purchase Sale Intangibles | -2,669 | -1,094 | -45 | -2,650 | -1,608 |
| Other Investing Activity | -2,669 | -1,094 | -45 | -2,650 | -1,608 |
| Investing Cash Flow | $298,735 | $123,898 | $8,263 | $-241,638 | $-204,308 |
| Cash Flows From Financing Activities | |||||
| Common Stock Repurchased | -72,191 | -32,404 | -24,655 | -106,986 | -54,921 |
| Dividend Paid | -500,000 | N/A | N/A | N/A | N/A |
| Financing Cash Flow | $-572,191 | $-32,404 | $-24,655 | $-106,986 | $-54,921 |
| Exchange Rate Effect | -1,815 | -155 | -670 | 1,147 | 2,228 |
| Beginning Cash Position | 576,611 | 576,611 | 576,611 | 600,399 | 600,399 |
| End Cash Position | 566,469 | 825,600 | 641,989 | 576,611 | 569,193 |
| Net Cash Flow | $-10,142 | $248,989 | $65,378 | $-23,788 | $-31,206 |
| Free Cash Flow | |||||
| Operating Cash Flow | 265,129 | 157,650 | 82,440 | 323,689 | 225,795 |
| Capital Expenditure | -19,526 | -12,135 | -6,078 | -26,886 | -17,742 |
| Free Cash Flow | 245,603 | 145,515 | 76,362 | 296,803 | 208,053 |